<DOC>
	<DOCNO>NCT01349413</DOCNO>
	<brief_summary>Background : Functional dyspepsia one commonest digestive disorder . The pathophysiology functional dyspepsia uncertain . Proton pump inhibitor ( PPI ) recommend first line treatment functional dyspepsia . However , result effectiveness PPI conflict suggest PPI effective acid-related symptom . The investigator plan use wireless pH monitoring system position junction esophagus stomach evaluate chronological relationship acid exposure region symptom dyspepsia well impact efficacy acid suppressive therapy treatment functional dyspepsia . Indication : Functional dyspepsia patient Study center ( ) : Prince Wales Hospital , Hong Kong Aims : 1 . To evaluate chronological relationship acid exposure squamo-columnar junction ( SCJ ) dyspeptic symptom different subtypes functional dyspepsia 2 . To evaluate relationship acid exposure squamo-columnar junction dyspeptic symptom response PPI 3 . To compare efficacy PPI placebo treat functional dyspepsia patient Study medication : Esomeprazole 20mg v Placebo o.d . Study design : Double-blind randomized placebo-controlled trial Number subject : 130 Patient population : Functional dyspepsia patient without concomitant gastroesophageal reflux disease ( GERD ) Duration study : 1 June 2010 - 30 May 2012 Primary variable ( ) : Proportion patient report positive response adequate relief dyspeptic symptom week 8 Secondary variable ( ) : Dyspeptic symptom score , symptom association probability dyspeptic symptom relation esophageal pH le 4 measure 1 cm SCJ . Number visit : 2 Hypothesis : Increased acid exposure SCJ contribute dyspeptic symptom predict treatment response PPI FD patient without concomitant GERD</brief_summary>
	<brief_title>BRAVO Study Functional Dyspepsia</brief_title>
	<detailed_description>Baseline assessment : All patient invite complete self-administered questionnaire demographic baseline symptom assessment - Demographics : age , gender - Screening functional gastrointestinal disorder base Rome III questionnaires - Functional dyspepsia symptom questionnaire : 8-item dyspeptic symptom score questionnaire use 4-point ( 0-3 ) Likert scale base recall past 7 day assessment epigastric pain , epigastric burning , belching , bloating , postprandial fullness , early satiation , nausea vomiting . Functional dyspepsia classify epigastric pain syndrome ( EPS ) postprandial distress syndrome ( PDS ) accord Rome III definition . - Global dyspeptic symptom assessment : dichotomous patient-reported scale ask give response either `` Yes '' `` No '' inquiry `` Do adequate relief dyspeptic symptom last 7 day ? '' - GERD symptom questionnaire : Patients also ask report frequency heartburn acid regurgitation last 3 month . Patients frequency reflux symptom twice per month deem concomitant GERD exclude study . - Psychological disorder : Patient Health Questionnaire ( PHQ ) use screen concomitant psychological disorder depression generalize anxiety disorder . Upper endoscopy BRAVO pH capsule insertion : Upper endoscopy arrange within 2 week baseline assessment order exclude organic pathology peptic ulcer , esophagitis neoplasm . The position morphology gastroesophageal junction assess withdrawal endoscope deflation stomach end-expiratory patient leave lateral body position . The morphology gastroesophageal junction grade accord `` flap valve '' concept . In order avoid confound effect gross anatomical disruption gastroesophageal junction acid exposure SCJ , patient grade IV disruption gastroesophageal junction , refers patulous hiatus axial displacement SCJ , exclude . After completion endoscopy examination , BRAVO delivery system pass orally esophagus body position . The endoscope reintroduce facilitate positioning delivery system direct visualization . The BRAVO pH capsule place 1 cm proximal SCJ monitoring acid exposure SCJ . Recording esophageal pH profile symptom : The wireless esophageal pH monitoring last 48 hour . During study period , patient instruct engage usual daily activity . The patient give diary documenting meal , sleep dyspeptic symptom . The patient return Bravo data recorder 48 hour . Randomization treatment : After completion BRAVO pH monitoring , patient randomly assign either esomeprazole 20mg daily identical look placebo 8 week . The random allocation sequence obtain computer-generated list random number block 10 . Concealed allocation achieve independent staff assign treatment accord consecutive number seal envelope . Study medication dispense seal package consecutive number . Medication adherence measure pill count final visit ( V2 ) . Follow-up assessment : The patient report individual dyspeptic symptom weekly basis use self administered symptom questionnaire . At week 4 week 8 , need give additional rating overall symptom response use global symptom assessment . The patient require give dichotomous response either `` yes '' `` '' question state `` Do adequate relief symptom past 7 day ? ''</detailed_description>
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Dyspepsia</mesh_term>
	<mesh_term>Esomeprazole</mesh_term>
	<criteria>Patients functional dyspepsia fulfill Rome III criterion inadequate relief dyspeptic symptom Age &gt; 18 Provision write consent Presence organic pathology identify upper endoscopy investigation Presence slide hiatus hernia define flap valve grade IV disruption morphology gastroesophageal junction Concurrent medication affect gastrointestinal motility Presence acid reflux heartburn symptom twice month History gastric surgery H. pylorus infection Use PPI NSAID past 4 week Pregnancy Known hypersensitivity PPI</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Functional dyspepsia</keyword>
	<keyword>symptom response</keyword>
	<keyword>postprandial fullness</keyword>
	<keyword>gastroesophageal reflux disease</keyword>
	<keyword>acid suppression</keyword>
</DOC>